www.peopleofthechange.com
Click here for more information about LiqofluxPhenometrics Buy 3 Get 1 Free
Visit cricatalyst.com!Evodos Separation Technology

Money

Sealantis Sells for $25 Million

February 6, 2019
AlgaeIndustryMagazine.com

The Sealantis team. Photo: Nitzan Zohar, Technion spokesperson’s office

Sealantis, which was established in Israel on the basis of technology developed at the Technion Institute, has been sold for US$25 million and royalties from future sales to Advanced Medical Solutions Group from England.

Sealantis develops medical adhesives based on technology from the Technion, which mimics the mechanism of adhesion of algae to rocks in water. “This is fundamental research inspired by a natural phenomenon that developed into applied technology, was patented and eventually became a product that will enable hundreds of thousands of patients to be treated.”

AMS, the acquiring company, is a manufacturer of innovative and technologically advanced products for the global surgical, wound closure and advanced wound care markets. This is their first acquisition in Israel, and Sealantis will be an innovation center for the multinational group. AMS’s products are sold in more than 75 countries, and the group has more than 600 employees.

Sealantis develops medical device products, based on a proprietary platform of alga-mimetic tissue adhesives, for a variety of applications in surgical adhesion. The company was established under the auspices of the AMIT Institute at the Technion, under the leadership of Prof. Havazelet Bianco-Peled, a world-renowned expert in biomedical polymers, from the Faculty of Chemical Engineering at the Technion.

The company’s present focus is on surgical seals designed to stop bleeding, prevent leakage of digestive tract contents into the abdominal cavity, prevent leakage of spinal fluid, and a variety of other applications.

The leading advantage of the technology is the fact that it is based on a polymer produced from algae, which does not contain proteins, and therefore the risk of infection or allergy is significantly lower than that of competing products produced from animals. The product does not require refrigerated transport and storage, it can be applied by spreading or spraying and is also suitable for use in laparoscopic surgery.

Tomer Fuchs, CEO of Sealantis, said that the connection with AMS increases the potential impact of the company’s products. “The journey of Sealantis is underway. The merger into AMS is an important milestone in the realization of our vision to enable medical teams around the world to prevent serious surgical complications thanks to Sealantis’ products.

“Following the merger, AMS will enjoy our scientific and engineering capabilities as an Israeli start-up company in the field of biotechnology, which includes innovation and the ability to bring simple and original solutions to complex challenges. AMS plans to expand operations in Israel, enabling it to expand into new, significant directions.”

More Like This…

Copyright ©2010-2020 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
Foodbev.com reports that French marine ingredients company Algaia will install a new specialty seaweed extract unit at its facility in Brittany, France, after securing €4...
Cornell University researchers have sequenced and analyzed the genome of a single-celled alga that belongs to the closest lineage to terrestrial plants and provides many ...
Marine ingredient start-up, Yemoja, Ltd., has created a next-gen platform for cultivating customized, pharmaceutical grade microalgae on demand. Founded three years ago b...
The Los Alamos Reporter highlights new research by New Mexico Consortium scientist, Joseph Msanne, along with colleagues Shawn Starkenburg and Juergen Polle, that looks a...
Jason Huffman writes in UndercurrentNews.com that the Kampachi Company, a mariculture business focused on expanding the environmentally sound production of sashimi-grade ...
Paris-based Solabia Group (“Solabia”) has acquired Algatech Ltd., a global leader in the development, cultivation and commercialization of ingredients delivered from micr...
Cécile Barbière writes for Euractive.fr (translated by Rob Kirby) that, in large greenhouses formerly home to the tomatoes and cucumbers of the market gardening Groupe Ol...
Skara Bohny reports in Stuff.co.nz that New Zealand’s Cawthron Institute is receiving funding as part of the High-Value Nutrition’s (HVN) National Science Challenge to de...
Members from ABO’s Future of Algae for Food and Feed and their stakeholders have laid out the next steps in launching an industry wide Algae Center of Excellence (ACE). T...
Due to the overall low thermodynamic efficiency (1 – 4%) of photosynthesis and its impact on crop productivity, substantial efforts are being made to engineer photosynthe...
Cyanotech Corporation, a Kailua Kona, Hawaii-based leader in high-value nutrition and health products made from algae, has announced financial results for the first quart...
Mazda is currently involved in joint research projects and studies as part of an ongoing industry-academia-government collaboration to promote the wide-spread adoption of...